Table 2. Number of patients enrolled in completed pediatric phase 3 epilepsy clinical trials.

	Number of patients enrolled (N = 27,587)	Median size of the trial (IQR)
Published trials	21,123 (77%) (N = 75 trials with available data)	207 (IQR 97 to 298)
	*20,575 (82%)(N = 74 trials with available data	*206 (IQR 98 to 396)
Unpublished trials	6,464 (23%)(N = 32 trials with available data)	97.5 (IQR 45 to 286)
	*4,437 (18%) (N = 24 trials with available data)	*85 (IQR 51 to 204)

*Trial was completed before 2014 (which takes into account the FDAAA deadline to publication of 1 year after completion). FDAAA = Food and Drug Administration Amendments Act of 2007